{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:38:26Z","timestamp":1791319106789,"version":"4.3.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T16:25:20Z","timestamp":1693844720000},"page":"199-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fibrotic Pulmonary Sarcoidosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Hilario","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Brillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bernaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Jeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2023.08.011_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2023.08.011_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0000000000000705","article-title":"Advanced pulmonary sarcoidosis","volume":"26","author":"Patel","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/rccm.202106-1366CI","article-title":"Management of advanced pulmonary sarcoidosis","volume":"205","author":"Gupta","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/17476348.2023.2183193","article-title":"An expert overview of pulmonary fibrosis in sarcoidosis","volume":"17","author":"Gupta","year":"2023","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/jid.1954.121","article-title":"Sarcoidosis and the Kveim Reaction1","volume":"23","author":"Rogers","year":"1954","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ccm.2023.08.011_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02992985","article-title":"Bronchoalveolar T lymphocytes and pulmonary sarcoidosis","volume":"3","author":"Hunninghake","year":"1985","journal-title":"Clin Rev Allergy"},{"key":"10.1016\/j.ccm.2023.08.011_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.74.2.122","article-title":"Nongranulomatous interstitial pneumonitis in sarcoidosis: Relationship to development of epithelioid granulomas","volume":"74","author":"Rosen","year":"1978","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib10","series-title":"Alveolitis and granulomas: sequential course in pulmonary sarcoidosis. Sarcoidosis and Other Granulomatous Disorders","first-page":"36","author":"Lacronique","year":"1983"},{"key":"10.1016\/j.ccm.2023.08.011_bib11","series-title":"Chapter 6 - Pathology of granuloma","first-page":"75","author":"Bernaudin","year":"2019"},{"key":"10.1016\/j.ccm.2023.08.011_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-015-8479-6","article-title":"Pathology of sarcoidosis","volume":"49","author":"Rossi","year":"2015","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.ccm.2023.08.011_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.humpath.2006.07.001","article-title":"Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung","volume":"38","author":"Kaarteenaho-Wiik","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ccm.2023.08.011_bib14","doi-asserted-by":"crossref","first-page":"220178","DOI":"10.1183\/16000617.0178-2022","article-title":"Immune mechanisms in fibrotic pulmonary sarcoidosis","volume":"31","author":"Weeratunga","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ccm.2023.08.011_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAS.0b013e3182785a2d","article-title":"End-stage sarcoid lung disease is distinct from usual interstitial pneumonia","volume":"37","author":"Xu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ccm.2023.08.011_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.03.005","article-title":"The clinical and immunologic features of pulmonary fibrosis in sarcoidosis","volume":"160","author":"Patterson","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.ccm.2023.08.011_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0040-1709495","article-title":"Advanced pulmonary sarcoidosis","volume":"41","author":"Gupta","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MCP.0b013e3283486d52","article-title":"Sarcoidosis and interstitial pulmonary fibrosis; two distinct disorders or two ends of the same spectrum","volume":"17","author":"Shigemitsu","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.15-0615","article-title":"Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis","volume":"149","author":"Zhang","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1183\/09031936.00150609","article-title":"Chronic interstitial pneumonitis in end-stage sarcoidosis","volume":"35","author":"Shigemitsu","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2169\/internalmedicine.45.1385","article-title":"Pulmonary sarcoidosis with usual interstitial pneumonia distributed predominantly in the lower lung fields","volume":"45","author":"Nobata","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/cells11040664","article-title":"Comparative analysis of gene expression in fibroblastic foci in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis","volume":"11","author":"Kamp","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ccm.2023.08.011_bib23","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.rmed.2018.08.008","article-title":"Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?","volume":"144S","author":"Collins","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/5584_2018_199","article-title":"Proangiogenic and profibrotic markers in pulmonary sarcoidosis","volume":"1114","author":"Tuleta","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ccm.2023.08.011_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1183\/09031936.00120410","article-title":"Transforming growth factor-{beta} gene polymorphisms in different phenotypes of sarcoidosis","volume":"38","author":"Pabst","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/ajrccm.154.3.8810610","article-title":"Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis","volume":"154","author":"Zissel","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib27","first-page":"213","article-title":"Circulatory TGF-beta1 is significantly higher in early stage of pulmonary sarcoidosis","volume":"35","author":"Mirsaeidi","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.011_bib28","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1378\/chest.129.6.1584","article-title":"Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis","volume":"129","author":"Kruit","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-0039.2010.01590.x","article-title":"Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis","volume":"77","author":"Heron","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.ccm.2023.08.011_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.02.00022302","article-title":"Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF","volume":"20","author":"Henry","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A\u00a0vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ccm.2023.08.011_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the mTOR, Rac1, and autophagy Triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ccm.2023.08.011_bib35","doi-asserted-by":"crossref","first-page":"2002950","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/gene.2012.48","article-title":"Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans","volume":"14","author":"Levin","year":"2013","journal-title":"Genes Immun"},{"key":"10.1016\/j.ccm.2023.08.011_bib37","article-title":"Current Insights in genetics of sarcoidosis: functional and clinical impacts","volume":"9","author":"Calender","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib38","doi-asserted-by":"crossref","first-page":"e0217005","DOI":"10.1371\/journal.pone.0217005","article-title":"Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages","volume":"14","author":"Jumeau","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2023.08.011_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like Receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1183\/09031936.00086410","article-title":"Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas","volume":"37","author":"Kambouchner","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib41","doi-asserted-by":"crossref","first-page":"719009","DOI":"10.3389\/fimmu.2021.719009","article-title":"Hypoxia promotes a mixed inflammatory-fibrotic macrophages phenotype in active sarcoidosis","volume":"12","author":"Jeny","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2023.08.011_bib42","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.011_bib43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-021-01818-5","article-title":"Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis","volume":"22","author":"Ronsmans","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2023.08.011_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cei.13519","article-title":"Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype","volume":"203","author":"Beijer","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ccm.2023.08.011_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chest.2016.01.020","article-title":"Association between occupational exposures and sarcoidosis: an analysis from death Certificates in the United States, 1988-1999","volume":"150","author":"Liu","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1183\/09031936.01.00056201","article-title":"Sarcoidosis severity and socioeconomic status","volume":"18","author":"Rabin","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. Patients with sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib49","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1378\/chest.08-1876","article-title":"Changes in chest Roentgenogram of sarcoidosis patients during a clinical trial of Infliximab therapy","volume":"136","author":"Baughman","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib50","first-page":"130","article-title":"Optimal scoring of serial change on chest radiography in sarcoidosis","volume":"28","author":"Zappala","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.011_bib51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib52","first-page":"e2022018","article-title":"Imaging findings of fibrosis in pulmonary sarcoidosis","volume":"39","author":"Sawahata","year":"2022","journal-title":"Sarcoidosis, Vasculitis and Diffuse Lung Disease"},{"key":"10.1016\/j.ccm.2023.08.011_bib53","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ccm.2023.08.011_bib54","doi-asserted-by":"crossref","first-page":"105650","DOI":"10.1016\/j.rmed.2019.02.022","article-title":"Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): a novel disease phenotype?","volume":"160","author":"Bianchi","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib55","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/jcm11072065","article-title":"Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): a new phenotype or a Fortuitous overlap? Scoping review and case series","volume":"11","author":"Bergantini","year":"2022","journal-title":"JCM"},{"key":"10.1016\/j.ccm.2023.08.011_bib56","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.chest.2020.04.074","article-title":"Mixed ventilatory defects in pulmonary sarcoidosis","volume":"158","author":"Kouranos","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib59","doi-asserted-by":"crossref","first-page":"105997","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib60","doi-asserted-by":"crossref","first-page":"106371","DOI":"10.1016\/j.rmed.2021.106371","article-title":"Antifibrotic drugs for pulmonary sarcoidosis: a treatment in search of an indication","volume":"180","author":"Judson","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib61","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/thoraxjnl-2016-208833","article-title":"CTAS: a CT score to quantify disease activity in pulmonary sarcoidosis","volume":"71","author":"Benamore","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2023.08.011_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.semnuclmed.2022.08.004","article-title":"FDG PET\/CT imaging of sarcoidosis","volume":"53","author":"R\u00e9gis","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib63","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib64","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2169\/internalmedicine.51.7394","article-title":"A\u00a0case of combined sarcoidosis and usual interstitial pneumonia","volume":"51","author":"Tachibana","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rmed.2018.10.029","article-title":"Response to Letter to Editor regarding \u2018Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?","volume":"149","author":"Collins","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib66","doi-asserted-by":"crossref","first-page":"105668","DOI":"10.1016\/j.rmed.2019.03.021","article-title":"Sarcoidosis and idiopathic pulmonary fibrosis: the same tale or a tale of two diseases in one","volume":"160","author":"Collins","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib67","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.rmed.2018.10.005","article-title":"Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): Genuine disease entity, obscure clinical phenotype or diagnostic red herring?","volume":"144","author":"Morgenthau","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib68","doi-asserted-by":"crossref","first-page":"2000767","DOI":"10.1183\/13993003.00767-2020","article-title":"Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study","volume":"56","author":"Rossides","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib69","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/resp.14001","article-title":"Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: a retrospective \u2018target trial\u2019 emulated with Swedish real-world data","volume":"26","author":"Rossides","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2023.08.011_bib70","doi-asserted-by":"crossref","first-page":"e8846","DOI":"10.1097\/MD.0000000000008846","article-title":"Severe infections in sarcoidosis: incidence, predictors and long-term outcome in a cohort of 585 patients","volume":"96","author":"Dur\u00e9ault","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.ccm.2023.08.011_bib71","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamadermatol.2017.1162","article-title":"Efficacy and tolerance of anti\u2013tumor necrosis factor \u03b1 agents in Cutaneous sarcoidosis: a French study of 46 cases","volume":"153","author":"Heidelberger","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ccm.2023.08.011_bib72","doi-asserted-by":"crossref","first-page":"1602396","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib73","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1378\/chest.12-1060","article-title":"Acute pulmonary exacerbations of sarcoidosis","volume":"142","author":"Panselinas","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib74","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.rmed.2013.10.014","article-title":"Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients","volume":"107","author":"Baughman","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib75","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/ijerph15061077","article-title":"Short-term particulate air pollution exposure is associated with increased severity of respiratory and quality of life symptoms in patients with fibrotic sarcoidosis","volume":"15","author":"Pirozzi","year":"2018","journal-title":"IJERPH"},{"key":"10.1016\/j.ccm.2023.08.011_bib76","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib77","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in Adults: an Official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib78","doi-asserted-by":"crossref","first-page":"2103187","DOI":"10.1183\/13993003.03187-2021","article-title":"Progressive pulmonary fibrosis: an expert group consensus statement","volume":"61","author":"Rajan","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib79","doi-asserted-by":"crossref","first-page":"2102571","DOI":"10.1183\/13993003.02571-2021","article-title":"Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry","volume":"60","author":"Hambly","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-022-02094-7","article-title":"Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis","volume":"23","author":"Schimmelpennink","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2023.08.011_bib81","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases\u2014subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib82","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1159\/000509556","article-title":"Progressive fibrosing interstitial lung diseases: prevalence and Characterization in two Italian referral centers","volume":"99","author":"Faverio","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.ccm.2023.08.011_bib83","doi-asserted-by":"crossref","first-page":"106626","DOI":"10.1016\/j.rmed.2021.106626","article-title":"Defining and predicting progression in non-IPF interstitial lung disease","volume":"189","author":"Goos","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib84","doi-asserted-by":"crossref","first-page":"790204","DOI":"10.3389\/fphar.2021.790204","article-title":"Outcomes and incidence of PF-ILD according to different definitions in a real-world Setting","volume":"12","author":"Torrisi","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ccm.2023.08.011_bib85","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12931-021-01879-6","article-title":"Progressive fibrosing interstitial lung disease: prevalence and clinical outcome","volume":"22","author":"Kwon","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2023.08.011_bib86","doi-asserted-by":"crossref","first-page":"23988","DOI":"10.1038\/s41598-021-03481-8","article-title":"Real-life prevalence of progressive fibrosing interstitial lung diseases","volume":"11","author":"Gagliardi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ccm.2023.08.011_bib87","doi-asserted-by":"crossref","first-page":"2003358","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: outcome and prognostic factors","volume":"58","author":"Le Pavec","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib88","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.rmed.2018.03.028","article-title":"Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003\u20132015: a nationwide population-based study","volume":"144","author":"Park","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib89","doi-asserted-by":"crossref","first-page":"1701815","DOI":"10.1183\/13993003.01815-2017","article-title":"Sarcoidosis mortality in Sweden: a population-based cohort study","volume":"51","author":"Rossides","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib90","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/resp.14202","article-title":"Sarcoidosis-related mortality and the impact of corticosteroid treatment: a population-based cohort study","volume":"27","author":"Sikj\u00e6r","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2023.08.011_bib91","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib92","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2018.11.010","article-title":"Sarcoidosis deaths in the United States: 1999\u20132016","volume":"149","author":"Kearney","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.011_bib94","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.011_bib95","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.08.011_bib96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS Clinical Statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2023.08.011_bib97","first-page":"e2022011","article-title":"Pirfenidone for fibrotic sarcoidosis (PIRFS): results of a double blind placebo controlled feasibility study","volume":"39","author":"Baughman","year":"2022","journal-title":"Sarcoidosis, Vasculitis and Diffuse Lung Disease"},{"key":"10.1016\/j.ccm.2023.08.011_bib98","first-page":"e2021035","article-title":"Roflumilast (Daliresp\u00ae) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial","volume":"38","author":"Baughman","year":"2021","journal-title":"Sarcoidosis, Vasculitis and Diffuse Lung Disease"},{"key":"10.1016\/j.ccm.2023.08.011_bib99","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000514917","article-title":"The Short- and long-term impact of pulmonary rehabilitation in Subjects with sarcoidosis: a prospective study and review of the literature","volume":"100","author":"Guber","year":"2021","journal-title":"Respiration"},{"key":"10.1016\/j.ccm.2023.08.011_bib100","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2021","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccm.2023.08.011_bib101","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1002\/hsr2.109","article-title":"Daily life physical activity in patients with chronic stage IV sarcoidosis: a multicenter cohort study","volume":"2","author":"Froidure","year":"2019","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.ccm.2023.08.011_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resmer.2019.10.003","article-title":"Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: a randomized controlled trial","volume":"77","author":"Wallaert","year":"2020","journal-title":"Respiratory Medicine and Research"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:10Z","timestamp":1759454290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272523123000801"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.011","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrotic Pulmonary Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}